The global Middle East and Asia Pacific biotechnology market is projected to grow at a CAGR of 7.2% between 2024 and 2031. Ending sentence: The Global Middle East and Asia Pacific Biotechnology Market is estimated to be valued at US$ 328.64 Mn in 2024 and is expected to exhibit a CAGR of 7.2% over the forecast period 2024 to 2031.Key Takeaways Key players operating in the Middle East And Asia...